[Ultraviolet spectrophotometry in the control of drugs. XXVII. New therapeutic substances containing chromophores of benzene rings in their molecules. 3. The effect of substitution and solvents].
D001418:Baclofen / Q000032:analysis; D002712:Chlorides / Q000032:analysis; D007052:Ibuprofen / Q000032:analysis; D007093:Imidazoles / Q000032:analysis; D007654:Ketoconazole; D004364:Pharmaceutical Preparations / Q000032:analysis*; D010879:Piperazines / Q000032:analysis; D012459:Salicylates / Q000032:analysis; D012997:Solvents; D013056:Spectrophotometry, Ultraviolet; D013726:Terbutaline / Q000032:analysis; D014988:Xipamide / Q000032:analysis
D002712:Chlorides; D007093:Imidazoles; D004364:Pharmaceutical Preparations; D010879:Piperazines; D012459:Salicylates; D012997:Solvents; D014988:Xipamide; D001418:Baclofen; D013726:Terbutaline; D007654:Ketoconazole; D007052:Ibuprofen
Ultrafialová spektrofotometrie v kontrole léciv. XXVIII. Nové lécivé látky s chromofory benzenových jader v molekulách. 3. Vliv substituce a rozpoustĕdel.